These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 20810219)
1. Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD. Silverman DH; Geist CL; Kenna HA; Williams K; Wroolie T; Powers B; Brooks J; Rasgon NL Psychoneuroendocrinology; 2011 May; 36(4):502-13. PubMed ID: 20810219 [TBL] [Abstract][Full Text] [Related]
2. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens. Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Khaylis A; Rasgon NL Am J Geriatr Psychiatry; 2011 Sep; 19(9):792-802. PubMed ID: 21873835 [TBL] [Abstract][Full Text] [Related]
3. Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia. Rasgon NL; Geist CL; Kenna HA; Wroolie TE; Williams KE; Silverman DH PLoS One; 2014; 9(3):e89095. PubMed ID: 24622517 [TBL] [Abstract][Full Text] [Related]
4. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. Kantarci K; Lowe VJ; Lesnick TG; Tosakulwong N; Bailey KR; Fields JA; Shuster LT; Zuk SM; Senjem ML; Mielke MM; Gleason C; Jack CR; Rocca WA; Miller VM J Alzheimers Dis; 2016 May; 53(2):547-56. PubMed ID: 27163830 [TBL] [Abstract][Full Text] [Related]
5. Distinct cognitive effects of estrogen and progesterone in menopausal women. Berent-Spillson A; Briceno E; Pinsky A; Simmen A; Persad CC; Zubieta JK; Smith YR Psychoneuroendocrinology; 2015 Sep; 59():25-36. PubMed ID: 26010861 [TBL] [Abstract][Full Text] [Related]
6. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. Zhao L; Brinton RD BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397 [TBL] [Abstract][Full Text] [Related]
7. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Araújo DA; Farias ML; Andrade AT Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087 [TBL] [Abstract][Full Text] [Related]
8. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS). Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767 [TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone treatment alters neural pathways but does not improve verbal cognitive function. Berent-Spillson A; Kelley AS; Persad CC; Love T; Frey KA; Reame NE; Koeppe R; Zubieta JK; Smith YR Menopause; 2018 Dec; 25(12):1424-1431. PubMed ID: 29994967 [TBL] [Abstract][Full Text] [Related]
10. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women. Edlefsen KL; Jackson RD; Prentice RL; Janssen I; Rajkovic A; O'Sullivan MJ; Anderson G Menopause; 2010; 17(3):622-9. PubMed ID: 20215977 [TBL] [Abstract][Full Text] [Related]
11. Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease. Wroolie TE; Kenna HA; Williams KE; Rasgon NL Am J Geriatr Psychiatry; 2015 Nov; 23(11):1117-26. PubMed ID: 26209223 [TBL] [Abstract][Full Text] [Related]
12. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women. Sherwin BB; Grigorova M Fertil Steril; 2011 Aug; 96(2):399-403. PubMed ID: 21703613 [TBL] [Abstract][Full Text] [Related]
15. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016 [TBL] [Abstract][Full Text] [Related]
16. [Basic principles of hormone replacement therapy in the postmenopause]. Dören M Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women. Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M Menopause; 2018 Nov; 25(11):1214-1223. PubMed ID: 30358716 [TBL] [Abstract][Full Text] [Related]